A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy
Blockade of the interleukin-1 (IL-1) pathway has been used therapeutically in several inflammatory diseases including arthritis and cryopyrin-associated periodic syndrome (CAPS). These conditions frequently affect women of childbearing age and continued usage of IL-1 specific treatments throughout p...
Main Authors: | Marie-Eve Brien, Virginie Gaudreault, Katia Hughes, Dexter J. L. Hayes, Alexander E. P. Heazell, Sylvie Girard |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/1/225 |
Similar Items
-
Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders
by: Dennis D. Arnold, et al.
Published: (2022-07-01) -
IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives
by: Hana Malcova, et al.
Published: (2021-02-01) -
The efficacy of anti‐IL‐1 targeted therapy in PAPA and PASH syndrome
by: Chloé Challamel, et al.
Published: (2022-09-01) -
IL-1 inhibition in systemic juvenile idiopathic arthritis
by: Gabriella Giancane, et al.
Published: (2016-12-01) -
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study
by: Antonio Vitale, et al.
Published: (2016-10-01)